You have read all your free articles, to continue reading subscribe to read the rest of this content.
Norwegian Targovax has entered an agreement with the shareholders of Finnish clinical-stage biotechnology company Oncos Therapeutics to acquire the shares of Oncos with settlement in Targovax shares. After the transaction, the shareholders of Oncos will own 50 per cent of Targovax. The new compAlready a subscriber Login You have read all your…
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. have announced that the European Commission has approved Rxulti (brexpiprazole) for the treatment of schizophrenia in adults. The approval follows the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) on May 31Already a subscriber Login You have…
Cantargia has announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion for orphan designation of nadunolimab (CAN04) for treatment of pancreatic cancer. The European Commission is now expected to grant the orphan designAlready a subscriber Login You have read…
AstraZeneca Chief Executive Officer Pascal Soriot told the audience at the J.P. Morgan Healthcare Conference in San Francisco, CA, that he is not worried about predictions that payers such as Express Scripts will be ramping up the pressure on global pharmaceutical companies to reduce drug prices. Already a subscriber Login…
